Mouthwash of Pomegranate Against Biofilm and Gingival Inflammation in School Children
NCT ID: NCT02949583
Last Updated: 2016-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2012-03-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Punica granatum Linn.
The childrens used the mouthwash contain pomegranate 6,25% twice daily for 14 days.
Punica granatum Linn.
Mouthwash (6,25% of Punica granatum Linn) 10mL per day during 14 days
chlorhexidine
The childrens used the mouthwash contain chlorhexidine 0.12% twice daily for 14 days.
chlorhexidine
standard anti-bacterial mouthwash Mouthwash (0,12% chlorhexidine) 10mL per day during 14 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Punica granatum Linn.
Mouthwash (6,25% of Punica granatum Linn) 10mL per day during 14 days
chlorhexidine
standard anti-bacterial mouthwash Mouthwash (0,12% chlorhexidine) 10mL per day during 14 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of at least 20 teeth
* Simplified Oral Hygiene Index (S-OHI)≥ 1,6
Exclusion Criteria
* Recent (in the past 2 months)use of antibiotics and mouthwashes
9 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual da Paraiba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DANÚBIA ROBERTA DE MEDEIROS NÓBREGA
Professor clinical
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DANÚBIA RM NÓBREGA, Mastering
Role: PRINCIPAL_INVESTIGATOR
Universidade Estadual da Paraiba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Estadual Da Paraiba
Campina Grande, Paraíba, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Menezes SM, Cordeiro LN, Viana GS. Punica granatum (pomegranate) extract is active against dental plaque. J Herb Pharmacother. 2006;6(2):79-92.
Bhadbhade SJ, Acharya AB, Rodrigues SV, Thakur SL. The antiplaque efficacy of pomegranate mouthrinse. Quintessence Int. 2011 Jan;42(1):29-36.
DiSilvestro RA, DiSilvestro DJ, DiSilvestro DJ. Pomegranate extract mouth rinsing effects on saliva measures relevant to gingivitis risk. Phytother Res. 2009 Aug;23(8):1123-7. doi: 10.1002/ptr.2759.
Vasconcelos LC, Sampaio FC, Sampaio MC, Pereira Mdo S, Higino JS, Peixoto MH. Minimum inhibitory concentration of adherence of Punica granatum Linn (pomegranate) gel against S. mutans, S. mitis and C. albicans. Braz Dent J. 2006;17(3):223-7. doi: 10.1590/s0103-64402006000300009.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Effectiveness of Pomegranate
Identifier Type: -
Identifier Source: org_study_id